A detailed history of British Columbia Investment Management Corp transactions in Moderna, Inc. stock. As of the latest transaction made, British Columbia Investment Management Corp holds 54,342 shares of MRNA stock, worth $2 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
54,342
Previous 62,327 12.81%
Holding current value
$2 Million
Previous $7.4 Million 50.94%
% of portfolio
0.02%
Previous 0.05%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$63.64 - $125.14 $508,165 - $999,242
-7,985 Reduced 12.81%
54,342 $3.63 Million
Q2 2024

Aug 14, 2024

BUY
$101.21 - $166.61 $2.39 Million - $3.94 Million
23,633 Added 61.08%
62,327 $7.4 Million
Q1 2024

May 14, 2024

BUY
$85.37 - $115.44 $124,127 - $167,849
1,454 Added 3.9%
38,694 $4.12 Million
Q4 2023

Feb 14, 2024

BUY
$69.51 - $104.43 $540,231 - $811,629
7,772 Added 26.37%
37,240 $3.7 Million
Q3 2023

Nov 14, 2023

SELL
$96.41 - $126.61 $9,544 - $12,534
-99 Reduced 0.33%
29,468 $3.04 Million
Q2 2023

Aug 11, 2023

BUY
$118.5 - $160.53 $56,880 - $77,054
480 Added 1.65%
29,567 $3.59 Million
Q1 2023

May 12, 2023

SELL
$135.66 - $197.02 $49,651 - $72,109
-366 Reduced 1.24%
29,087 $4.47 Million
Q4 2022

Feb 10, 2023

SELL
$118.38 - $210.04 $480,741 - $852,972
-4,061 Reduced 12.12%
29,453 $5.29 Million
Q3 2022

Nov 10, 2022

SELL
$118.07 - $194.18 $734,277 - $1.21 Million
-6,219 Reduced 15.65%
33,514 $3.96 Million
Q2 2022

Aug 12, 2022

SELL
$117.13 - $176.59 $1.58 Million - $2.38 Million
-13,469 Reduced 25.32%
39,733 $5.68 Million
Q1 2022

May 12, 2022

SELL
$126.46 - $235.05 $906,465 - $1.68 Million
-7,168 Reduced 11.87%
53,202 $9.17 Million
Q4 2021

Feb 11, 2022

SELL
$225.82 - $368.51 $619,424 - $1.01 Million
-2,743 Reduced 4.35%
60,370 $15.3 Million
Q3 2021

Nov 12, 2021

BUY
$221.9 - $484.47 $988,120 - $2.16 Million
4,453 Added 7.59%
63,113 $24.3 Million
Q2 2021

Aug 09, 2021

BUY
$129.91 - $234.98 $1.73 Million - $3.12 Million
13,292 Added 29.3%
58,660 $13.8 Million
Q1 2021

Apr 30, 2021

SELL
$109.18 - $185.98 $150,668 - $256,652
-1,380 Reduced 2.95%
45,368 $5.94 Million
Q4 2020

Feb 02, 2021

SELL
$65.74 - $169.86 $29,714 - $76,776
-452 Reduced 0.96%
46,748 $4.88 Million
Q3 2020

Nov 10, 2020

BUY
$54.34 - $94.85 $194,754 - $339,942
3,584 Added 8.22%
47,200 $3.34 Million
Q2 2020

Aug 12, 2020

BUY
$29.67 - $80.0 $1.29 Million - $3.49 Million
43,616 New
43,616 $2.8 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track British Columbia Investment Management Corp Portfolio

Follow British Columbia Investment Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of British Columbia Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on British Columbia Investment Management Corp with notifications on news.